Insider: Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER - Enliven Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,123 | 740,188 | 742,311 |
| Value | $82,436.09 | $28,741,500.04 | $28,823,936.13 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/06/2026 | DDS | 5,000 | Indirect | COM | $29.04 | $145,219.00 | 740,188 |
| 01/20/2026 | DDS | 5,491 | Indirect | COM | $26.37 | $144,814.14 | 759,697 |
| 01/20/2026 | DDS | 14,509 | Indirect | COM | $26.90 | $390,284.85 | 745,188 |
| 01/09/2026 | DDS | 41,198 | Indirect | COM | $24.90 | $1,025,863.16 | 815,188 |
| 01/09/2026 | DDS | 50,000 | Indirect | COM | $29.13 | $1,456,715.00 | 765,188 |
| 01/08/2026 | DDS | 7,500 | Indirect | COM | $20.13 | $150,961.50 | 890,188 |
| 01/08/2026 | DDS | 33,802 | Indirect | COM | $24.92 | $842,474.29 | 856,386 |
| 12/19/2025 | DDS | 5,000 | Indirect | COM | $16.84 | $84,206.00 | 897,688 |
| 11/19/2025 | DDS | 12,008 | Indirect | COM | $22.30 | $267,794.01 | 903,180 |
| 11/19/2025 | DDS | 492 | Indirect | COM | $23.09 | $11,360.77 | 902,688 |
| 10/20/2025 | DDS | 12,500 | Indirect | COM | $22.08 | $276,025.00 | 915,188 |
| 09/26/2025 | DDS | 4,000 | Indirect | COM | $20.25 | $81,005.20 | 927,688 |
| 09/23/2025 | DDS | 1,500 | Indirect | COM | $20.03 | $30,045.00 | 931,688 |
| 09/19/2025 | DDS | 4,870 | Indirect | COM | $19.11 | $93,063.27 | 935,318 |
| 09/19/2025 | DDS | 2,130 | Indirect | COM | $20.02 | $42,634.08 | 933,188 |
| 08/21/2025 | DDS | 7,500 | Indirect | COM | $20.01 | $150,099.00 | 940,188 |
| 08/19/2025 | DDS | 5,000 | Indirect | COM | $19.62 | $98,117.50 | 947,688 |
| 07/21/2025 | DDS | 11,924 | Indirect | COM | $22.26 | $265,458.05 | 953,264 |
| 07/21/2025 | DDS | 576 | Indirect | COM | $22.90 | $13,187.75 | 952,688 |
| 06/20/2025 | DDS | 12,500 | Indirect | COM | $21.40 | $267,457.50 | 965,188 |
| 06/03/2025 | DDS | 7,500 | Indirect | COM | $20.03 | $150,219.75 | 977,688 |
| 05/19/2025 | DDS | 5,000 | Indirect | COM | $16.31 | $81,533.50 | 985,188 |
| 05/02/2025 | DDS | 2,470 | Indirect | COM | $20.01 | $49,424.45 | 990,188 |
| 05/01/2025 | DDS | 5,030 | Indirect | COM | $20.07 | $100,966.18 | 992,658 |
| 04/21/2025 | DDS | 330 | Indirect | COM | $16.72 | $5,517.86 | 997,688 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research